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Abstract
Background: Type I interferons are major players against viral infections and mediate their function by the
induction of Interferon regulated genes (IRGs). Recently, it became obvious that these cytokines have a multitude
of additional functions. Due to the unique features of the chickens’ immune system, available data from mouse
models are not easily transferable; hence we performed an extensive analysis of chicken IRGs.
Results: A broad database search for homologues to described mammalian IRGs (common IRGs, cIRGs) was
combined with a transcriptome analysis of spleen and lung at different time points after application of IFNα. To
apply physiological amounts of IFN, half-life of IFN in the chicken was determined. Interestingly, the calculated
36 min are considerably shorter than the ones obtained for human and mouse. Microarray analysis revealed many
additional IRGs (newly identified IRGs; nIRGs) and network analysis for selected IRGs showed a broad interaction of
nIRGs among each other and with cIRGs. We found that IRGs exhibit a highly tissue and time specific expression
pattern as expression quality and quantity differed strongly between spleen and lung and over time. While in the
spleen for many affected genes changes in RNA abundance peaked already after 3 h, an increasing or plateau-like
regulation after 3, 6 and 9 h was observed in the lung.
Conclusions: The induction or suppression of IRGs in chickens is both tissue and time specific and beside known
antiviral mechanisms type I IFN induces many additional cellular functions. We confirmed many known IRGs and
established a multitude of so far undescribed ones, thus providing a large database for future research on antiviral
mechanisms and additional IFN functions in non-mammalian species.
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Background
Interferons (IFNs) are cytokines critically involved in the
control of viral, bacterial, fungal and parasitic infections.
They mediate their activity either directly or indirectly
through the induction of regulators of innate and adap-
tive immune cells [1]. Three families of IFNs have been
described in mammals. In humans type I IFNs form a
multigene family with 13 members of closely related
IFNα genes, a single distinct IFNβ gene. These cytokines
are best known for their antiviral activity and were the
first IFNs identified [2, 3]. In addition, there are genes
for IFNε, IFNκ, and IFNω, whose function is less well
characterized [1]. Type II IFN is represented by a single
gene encoding IFNγ. IFNγ has pleiotropic effects on
cells of the immune system and is known as a potent
activator of macrophages [4]. More recently, a third IFN
family was uncovered named type III IFN which in
humans comprises four IFNλ genes. IFNλs exert similar
responses as type I IFNs but their activity is largely
restricted to epithelial tissues as a consequence of the
restricted expression of IFNλ receptors [5]. Type I IFNs
are induced in response to viral infections in most cell
types. Viral infections are sensed by the cells through
pattern recognition receptors (PRRs) located in the
cytoplasm or the endosomal compartment. RIG-I and
MDA-5 are the primary but not only cytosolic sensors
recognizing RNA. The endosomal PRRs (TLR3, TLR7/8)
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are double and single stranded RNA sensors of the Toll-
like receptor (TLR) family. In contrast, TLR9 binds
unmethylated CpG DNA. Upon ligand binding these PRRs
activate downstream signals such as IRF3 and IRF7 which
induce IFN gene transcription and secretion [6, 7].
Type I IFNs bind to a common receptor (interferon-α/β
receptor (IFNAR)) expressed on most cell types. Ligation
of the heterodimeric receptor activates the JAK/STAT
signaling pathway which leads to phosphorylation of
STAT1 and STAT2 and together with IRF9 to the forma-
tion of the ISGF3 complex which induces transcription of
IFN regulated genes (IRGs) through binding to IRG re-
sponse elements [8]. Several IRGs have been studied in
great detail including myxovirus resistance 1 (MX1), IFN-
inducible double-stranded RNA-dependent protein kinase
(PKR), 2’-‘5-oligoadenylate synthetase (OAS) and IFN
induced transmembrane proteins (IFITMs) [9]. Besides
this canonical pathway, type I IFNs induce the formation
of STAT1 homodimers and the induction of γ-activated
sequences (GAS) in promoter regions typically activated
by IFNγ. Furthermore, signaling through STATs 3, 4 and 5
has been described. While signaling through the STAT1/
STAT2 pathway induces classical antiviral responses, alter-
native signaling leads to the production of a broad range
of cytokines, chemokines, antimicrobial products and
regulators of apoptotic pathways [10]. Transcriptomic
studies have shown the induction of hundreds of
genes upon type I IFN receptor ligation in vitro and
in vivo [11–13]. Recently, based on these studies large
scale screening systems were established to identify
IRGs that are induced by different viruses to elucidate
their functional relevance [10, 14].
While in-depth knowledge on the mammalian IFN
system has been accumulated over decades as outlined,
comparatively little is known in avian species. This is sur-
prising taken the fact that poultry flocks are worldwide
under intensive pressure by viral infections, which lead to
huge economic losses. Most recent examples are highly
pathogenic avian influenza (HPAI) outbreaks 2014/2015
in North America with estimated 50 million birds dead or
culled [15] or the constant threat by velogenic Newcastle
Disease outbreaks around the globe [16].
Members of all three IFN families have been identified
in different avian species such as chickens, turkeys and
ducks. In chickens the type I family is smaller than in
humans with approximately ten IFNα genes and a single
IFNβ gene [17, 18]. Cloning and expression of recombin-
ant proteins enabled functional studies and confirmed the
antiviral properties of avian type I IFNs in vitro and in vivo
as well as the induction of known IRGs including Mx,
OAS and PKR.
Though in general the mammalian and avian IFN sys-
tems appear quite similar, when studied in more detail
subtle differences became apparent between birds and
mammals and between individual bird species. In an
effort to get insights into the differences in HPAV infec-
tion outcomes between chicken and ducks, it was recog-
nized that galliformes lack the PRR RIG-I which strongly
induces type I IFN production in mice. As this molecule
is present in the duck genome and fully functional, this
lead to the conclusion that observed differences in
HPAIV susceptibility might result from insufficient acti-
vation of the type I IFN pathway in chickens [19]. How-
ever, work in chickens infected with the HPAIV H5N1
demonstrated rapid induction of IFNα transcripts and
protein indicating that alternative pathways such as
the MDA-5 and/or the TLR pathways may account
for the response [20]. Interestingly, such a loss in the
family of RIG-I like receptors was not only found in
birds but also in mammals as recently reported for
RIG-I in the Chinese tree shrew [21].
To a limited extent IRGs have been investigated in
more detail in birds [22–24]. In analogy to the mamma-
lian system the avian Mx orthologue was considered to
have potent antiviral properties [25, 26]. Surprisingly, in
vitro and in vivo studies clearly demonstrated that
chicken Mx does not limit influenza virus replication
despite strong induction of the protein by IFN [27, 28].
Thus, it remains to be elucidated which IRGs confer
antiviral resistance in different viral disease. Such know-
ledge is crucial to form breeding programs for increased
innate resistance and to understand the unique antiviral
properties amongst avian species.
To lay the foundation for future research we treated
chickens with recombinant IFNα at physiological plasma
levels and performed intensive gene expression analysis
in lung and spleen. Here we provide a comprehensive
list of chicken IRGs and show that in addition to com-
mon IRGs shared between mammals and chickens
unique chicken IRGs could be identified. This informa-
tion together with recently published in vitro studies will
allow large scale functional screens of IRGs as recently
reported in mammals [29].
Methods
Animals
Fertilized eggs of conventional White Leghorn chickens
(LSL) were obtained from Lohmann Tierzucht GmbH,
Cuxhaven, Germany and hatched at the Institute of
Animal Physiology, Munich. Birds were vaccinated
against Marek’s Disease Virus after hatch, housed under
conventional conditions in aviaries with groups up to
ten birds and received food and water ad libitum.
Interferon treatment of chickens
Recombinant chicken interferon alpha (rec chIFNα) was
expressed and purified from Escherichia coli as de-
scribed previously [30]. The concentration of chIFNα
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was determined using an internal standard initially quali-
fied with the international standard 67/18 (80 IU/ml) [31]
and reported in Units per ml (U/ml). For injection, appro-
priate amounts of rec chIFNα for pharmacokinetics and
the microarray study were dissolved in PBS (pH 7,2).
Pharmacokinetics
Six weeks old LSL chickens received a single i.v. injec-
tion of 1×107 Units for the biggest bird and a direct pro-
portional weight adjusted dose for all others. Plasma
samples were collected 5, 10, 15, 30, 60, 120, 240, 360
and 480 min after dosing and chIFNα levels were deter-
mined. Pharmacokinetic parameters were calculated by
Non Compartmental Analysis using Microsoft Excel® as
follows: The highest plasma concentration observed
(Cmax) as well as the corresponding time point (Tmax)
were directly derived from the time/concentration plot
for each individual animal. ChIFNα plasma Clearance (Cl)
was calculated as a direct function of dose and Area Under
the time/concentration Curve (AUC) (i.e. Cl = Dose/AUC).
AUC was determined using the linear-trapezoidal rule (i.e.
sum of the areas below the time/concentration curve
with a linear connection between consecutive data
points). The volume of distribution (Vz) as well as the
terminal elimination half-life (T1/2) were extrapolated
based on an exponential regression of the last three
time/concentration points.
Experimental design of the microarray experiment
Twenty-four six-week-old LSL chickens were divided
into four groups, a control group and three groups
which received 1x107U rec chIFNα into the V. jugularis
or V. cutenea ulnaris superficialis every 3 h. Birds were
sacrificed at three hours (one IFN application), six hours
(two IFN applications) and nine hours (three IFN appli-
cations) after the first treatment. The control group
received a single injection of buffer and was killed after
6 h. Blood samples of each animal were taken before
injection and before killing and obtained plasma was
stored at -80 °C. Spleen and lung samples were isolated
and stored in RNA later (Ambion, Warrington, UK) at
-80 °C until RNA isolation. Lung samples were taken by
selecting the second to last segment of the left lung
containing the primary and secondary bronchi of the
torus intercostalis.
IFN assay
Type I IFN activity in plasma samples was determined
using a bioassay based on the strong induction of the
Mx gene in the presence of type I IFN as described re-
cently [30]. Briefly, CEC-32 reporter cells containing a
luciferase gene under the chicken Mx promoter were
incubated with serial dilutions of plasma samples or the
chIFNα standard. After 6 h of incubation cells were
lysed with 100 μl of 1× cell culture lysis reagent (Promega,
Madison, USA) and luciferase activity was measured using
Luciferase substrate (Promega, Madison,USA) and a
Glomax 96 microplate luminometer (Promega, Madison,
USA).
IL6 assay
The amount of IL6 protein in plasma samples of rec
chIFNα treated chicken was measured by the ability of
added plasma to stimulate proliferation of the IL6-
dependent murine hybridoma cell line 7TD1 (kindly
provided by J. Van Snick, Ludwig Institute for Cancer
Research, Brussels, Belgium) essentially as described pre-
viously [32]. Briefly, 7TD1 cells were thoroughly washed
in PBS and cultured with 5×103 cells per well of a 96-
well flat-bottomed microtiter plate in medium (RPMI
1640 medium with Glutamax, 10% fetal bovine serum)
and serial twofold dilutions of the samples or of 1 ng/ml
E.coli derived recombinant chIL-6. Cells were cultured
for 4 days and proliferation was measured using the
XTT [2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phe-
nylamino)carbonyl)-2H-tetrazolium hydroxide] colori-
metric assay [33]. XTT (Sigma, Taufkirchen, Germany)
was diluted in RPMI 1640 medium to a final concentra-
tion of 1 mg/ml and phenazine methosulfate was added
to a final concentration of 0.025 mmol. Fifty microliters
of the XTT/phenazine methosulfate solution were added
to each well, and the cells were incubated at 37 °C and
5% CO2 for 4 h before absorbance was measured in a
photometer at 450 nm.
RNA isolation
Lung and spleen tissue was homogenized in peqGold
TriFast (Peqlab, Erlangen, Germany). Lung tissue was
homogenized with a rod homogenizer (Ultra-Turrax, IKA,
Staufen, Germany). Spleen tissue was homogenized with a
tissue homogenizer (Precellys 24, Peqlab, Erlangen,
Germany). Total RNA was isolated according to the
manufacturer’s Trizol protocol. Quantity and purity of ex-
tracted RNA was determined with a NanoDrop 1000
(PEQLAB Biotechnologie GMBH, Erlangen, Germany),
while the RNA quality was analysed using a 2100 Bioana-
lyzer® (Agilent Technologies, Böblingen, Germany). Only
RNA samples with an RNA integrity number (RIN) ex-
ceeding 8.4 were used for qRT-PCR and microarray
analysis.
Oligonucleotide microarray analysis
Microarray analysis was performed using Agilent 4×44K
chicken-genome microarrays, supplemented by the
addition of 1699 selected genes out of the chicken
genome, supposed to play a crucial role in the chicken
immune system (AMADID 23824). The best four out of
six lung and spleen samples of each group in the IFN
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experiment were hybridised. After hybridising, washing
and scanning of the microarrays image following manu-
facturer’s instructions (Agilent technologies, Santa Clara,
US), arrays were further processed with Feature Extrac-
tion Software 10.5.1.1 (Agilent Technologies). Processed
signals were filtered based on “Well above background”
flags (detection in three of four samples in either one of
the experimental groups) and normalized using the
BioConductor package vsn [34]. The quality of the nor-
malized data was checked with a distance matrix and a
heatmap following on pair-wise distances (BioConductor
package geneplotter). Significance analysis was performed
with the Microsoft Excel add-in “Significance analysis of
microarrays” (SAM; multiclass) [35]. With a False discov-
ery rate (FDR) <5% a fold change (FC) higher than 2 and
smaller than -2 was accepted as significant.
The original Agilent gene annotation was refined by
BLAST search in NCBI and Ensembl and by AvI-Blast, a
software especially designed to align oligonucleotide
sequences to the chicken genome database of NCBI.
Official gene symbols were obtained by online ID-
converter DAVID, Babelomics and g:Profiler. Multi ex-
periment viewer (MeV) was used for the generation of
expression profiles, PANTHER gene list analysis to map
genes to different gene ontology clusters. The INTER-
FEROME and ISG databases [11, 12, 36–39] were used
as sources for known mammalian IRGs.
Quantitative Real-Time RT-PCR
The same RNA samples as for the microarrays were used
for quantitative real-time RT-PCR. Genomic DNA was
eliminated by DNase I (Fermentas, St. Leon-Rot, Germany)
and 400 ng cDNA were generated using the GOScript
Reverse Transcription System (Promega Corporation,
Madison, USA) according to the manufacturer’s instruc-
tions. 10 ng cDNA of spleen and lung were analysed for
the relative abundance of 18S, Mx, IL6 and PKR RNA
with a GoTaq qPCR Master Mix (Promega Corporation,
Madison, USA). Primers for qRT-PCR were designed
using PerlPrimer software and obtained from Eurofins
MWG Operon [40]. The following forward and reverse
primers were used for qRT-PCR reactions: 18S rRNA:
forward primer 5′-CATGTCTAAGTACACACGGGC
GGTA-3′ and reverse primer 5-′GGCGCTCGTCG
GCATGTATTA-3′ IL6 forward primer 5′-GCTTCGAC
GAGGAGAAATGC-3′and reverse primer 5′-GCCA
GGTGCTTTGTGCTGTA-3′ Mx forward primer 5′-G
CGGACAAGCCATAGAACAAG-3′ and reverse pri-
mer 5′-GGCACCCCAAAAACTCCTACA-3′ PKR f
+orward primer 5′-GGAAGTAGACATTTATGCGCT
GG -3′and reverse primer 5′-CATCCTGCCATACC
TTGTTTTTCT-3′. Quantitative RT-PCR was per-
formed using a 7300 Real-Time PCR System® (Applied
Biosystems, Warrington, UK) with SYBR-green. Obtained
CT values were normalized to 18S rRNA (= dCT) and fold
changes were calculated in comparison to the control
group (2-ΔΔCT method).
Promotor-analysis
Sequences of differentially expressed and unaffected
genes were analysed for the existence of Interferon stim-
ulated response elements (ISRE) and/or Gamma acti-
vated sequence (GAS) elements in a first step by using
ISRE and GAS sequences earlier described by Tsukahara
et al. [41], who characterized functional ISRE and GAS
elements according to a particular algorithm (Additional
file 1: Table S1). As REFINEMENT, the search frame-
work specifically designed for an automated large scale
search for ISRE and/or GAS motifs isn’t available any-
more, we screened chicken genes with motifs, which
were described by Tsukahara et al. as “functional motifs”.
Based on the work of Schuhmacher et. al. [22] the se-
quence 6 kb upstream of the first exon was considered
as promotor region. In addition, the complete gene se-
quence was analysed from 6 kb upstream, including all
exons and introns. Screening of Ensembl based se-
quences was performed with a self-designed Shell script.
For a more detailed analysis the 30 genes with the high-
est changes in mRNA abundance after IFN injection
were individually searched for the existence of the com-
mon ISRE consensus 5′A/GGTTTCN(1-2)TTTCC/T3′
or its reverse complement and the common GAS con-
sensus 5′TTNCNNNAA3′ [42–45].
Results
Identification of IRGs by database analysis
In order to identify IRGs in the chicken we started with
an extensive comparative database analysis to relate
known mammalian IRGs to annotated chicken genes.
Therefore entries in INTERFEROME, the ISG-
database, KEGG [46], Reactome and several publica-
tions were combined and compared to all annotated
13,353 genes on a customized laboratory internal Agi-
lent 4x44K chicken Genome microarray. Thereby we
were able to identify 1420 genes, which are known as
mammalian IRGs and are also present in the chicken
genome. These genes were termed “common IRGs”
(cIRGs) (see Additional file 2: Table S2 for Gene de-
scription, Accession numbers and sequences). Using
the INTERFEROME database the identified cISGs were
also assigned to type I, type II and type III interferons
as inducers. From the identified 1420 ISGs, with 1192
the majority of genes are known to be induced by type
I interferon, 898 by type II and only 86 by type III,
though many IRGs are induced by several types of IFN
leading to an extensive overlap.
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Pharmacokinetics of rec chIFNα
Next, we wanted to confirm the in silico identified cIRGs
in vivo by treating chickens with recombinant chIFNα.
In order to obtain biological relevant plasma levels of
type I IFN for a longer time we first determined the
pharmacokinetic properties of rec chIFNα in the
chicken. Therefore, three adult chickens received a sin-
gle i.v. injection of rec chIFNα. Plasma samples were
collected at frequent intervals post dose and levels of
chIFNα were determined using a reporter-assay for
chicken type I IFN. Based on these results Cmax at
16,624 ± 1,985 U/ml was achieved as early as five mi-
nutes post application (i.e. the first sampling time point
post administration). The pharmacokinetic profile was
characterized by a 2-compartment profile consisting of
an initial distribution phase up to 60 min post injection
and followed by 2nd phase characterized by a first order
elimination. At 240 min post application the lower de-
tection limit of the bioanalytical assay was reached.
(Fig. 1). From these data a mean terminal half-live of
chIFNα was calculated at 36 min (SD 2.53 min, CV 7%).
A detailed overview on all pharmacokinetic parameters
calculated is provided in Additional file 3: Table S3.
Microarray based identification of chicken ISGs
Experimental setup
In order to evaluate chicken ISGs on the transcriptome level
rec chIFNα was applied to three groups of six week old
chickens according to the experimental scheme shown in
Fig. 2a. It is known from infection studies with a Newcastle
disease virus (NDV) vaccine or Highly pathogenic Avian in-
fluenza viruses (HPAIV) that endogenous plasma levels of
type I IFN range between 100 U/ml (NDV, own unpublished
observations) and 1,000 U/ml (HPAIV, [20]). Therefore,
based on the calculated half-life birds received an i.v. injec-
tion of 1×107 U chIFNα every 3h to obtain a constant bio-
logically relevant chIFN plasma level. After three (IFN(3 h)),
six (IFN(6 h)) and nine hours (IFN(9 h)), respectively, a
group of birds was killed and tissues were taken for RNA
isolation and microarray analysis. Lung parenchyme (with-
out BALT) was chosen as mucosal tissue serving as portal of
entry for many pathogens, while the spleen represents the
most prominent lymphatic tissue in the chicken. The con-
trol group received only buffer and was killed after 6 h.
To verify the treatment schedule plasma samples were
obtained before the first IFN injection and before tissue
sampling and analysed for the amount of chIFNα. While
no type I IFN was detectable in any of the samples be-
fore treatment (data not shown) and in the control
group, IFN treated groups had mean IFN plasma con-
centrations of 150 U/ml after three, 175 U/ml after six
and 200 U/ml after 9 h (see. Fig. 2b). This demonstrates
that the applied treatment schedule indeed led to a rela-
tively constant IFN exposure of the animals.
Identification of differentially abundant genes
RNA from spleen and lung samples was hybridized to
the customized Agilent 4x44K chicken array. Heatmap
analysis using “R” demonstrated that IFN treatment re-
sulted in significant transcriptome alterations and a dis-
tinct clustering of the different experimental groups
(Fig. 3a). In both tissues all control and IFN(3 h) samples
were clearly assigned to single groups, while for IFN(6 h)
and IFN(9 h) in spleen and lung one sample did not
group with the others. Interestingly, in the spleen, IFN-
induced transcriptome changes in the three hours group
were so pronounced, that the transcriptome after 6 and
9 h was closer related to controls than to this group. In
the lung, control samples show a distinct separation
from all IFN treated groups. Among the later IFN(3 h) is
clearly discriminable from the other time points, while
the transcriptome differences between 6 and 9 h were
less pronounced and some overlap could be observed.
This observation is also reflected by the number of sig-
nificantly regulated genes, that is genes with an FC ≤ -2
or ≥ 2 and an FDR ≤ 0.05. With 1870 (spleen) and 945
(lung), by far most regulated genes were identified in the
three hours group (Table 1). It is noticeable that in the
spleen at each time point down-regulated genes out-
number up-regulated ones, while in the lung three to
fivefold more up-regulated genes were identified.
A clear overlap exists between the genes regulated
after 3 h in lung and spleen, but many genes are also tis-
sue specific (Fig. 3b). Five hundred thirteen genes were
identified in both tissues representing about a quarter of
all genes regulated in the spleen and more than half of
the genes, which were regulated in the lung. When the























Fig. 1 Pharmacokinetic profile of recombinant ChIFNα after i.v.
injection. Three chickens were treated i.v. with a single dose of
recChIFNα (1x107Units for the biggest bird and a direct proportional
weight adjusted dose for the others). Plasma was taken at the
indicated time points, and the amount of biological active type I IFN
was determined using an IFN reportergene assay
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intersections were found, but in total only a quarter (381
genes, representing 17% of splenic genes and 23% of
lung genes) of the in silico identified cIRGs were also
found in the in vivo experiment. Forty-six additonal
cIRGs were found among the genes exclusively regulated
after IFN(6 h) and IFN(9 h).
A comparison between the different time points re-
vealed, that more than 60 and 50% of genes in the spleen
and lung, respectively, were solely regulated in the three
hours group. Seventy percent of splenic and 77% of lung
genes regulated after 6 h showed also an altered abun-
dance after 3 h. From the genes with altered abundance
after 9 h almost 90% of genes in the spleen and 75% of
genes in the lung were also found at earlier time points
(Fig. 3c). The percentage of cIRGs among these gene
subgroups was largely the same, ranging between 9 and
15% in the spleen and 13 and 23% in the lung.
Collectively, the observed variations in RNA abun-
dances were much stronger in the spleen than in the
lung. Fold changes for significantly regulated genes
ranged from a 685fold up-regulation of PTX3 (pentraxin
related gene, rapidly induced by IL1beta) to a 436fold
down-regulation of SFTPA1 (surfactant pulmonary-
associated protein A1) in the spleen (Table 2) and a
118fold up-regulation of TULP1 (tubby like protein 1) to
a 18fold down-regulation of IRG1 (immunoresponsive 1
homolog) in the lung (Table 2). Most of the highest fold
changes in both organs were found after 3 h, though for
some of the 30 genes with highest changes in RNA abun-
dance, e.g. SFTPA1 the highest value was achieved after 9
h of IFN exposition (Table 2). Also among these 30 genes
were the classical IRGs Mx1 and Oligoadenylate-Synthase
(OAS). With 36% (spleen) and 43% (lung) the percentage
of cIRGs among these genes is twofold higher than among
the entity of differentially expressed genes. The fact that
only 30% of the splenic genes with the strongest regulation
show also regulated expression in the lung and 23% of the
lung genes are regulated in the spleen, demonstrate an
distinct response to IFN stimulation in both organs.
Interestingly, with a 384fold and 44fold (spleen) and a
186fold and 67fold up-regulation (lung), mature avidin
(LOC396260) and IL6 (interleukin 6) were in both or-
gans among the five strongest regulated genes. It is also
noticeable that in the spleen several of the top 30 genes
were cytokines and chemokines (IL6, K203, CSF3, IL22).
The vast majority of transcriptome changes occurred 3
h after IFN aplication and for genes, which were solely
regulated at later time points, the regulation due to sec-
ondary effects becomes more likely. Hence, we decided
to use only those genes which were regulated after 3 h
for further analysis. Regulated genes which were not
identified as cIRGs were termed as “newly identified
IRGs” (nIRGs).
Promotor analysis
Interferons function by receptor binding, activation of the
JAK-STAT-pathway and finally binding of transcription
factors to DNA regulatory elements in upstream regions
of target genes: these are the so called interferon-
stimulated response elements (ISREs) and gamma-
activated sequences (GASs). In order to test whether the
identified nIRGs could be activated by either of these re-
sponse elements, we searched for ISREs and GASs in the
respective genes.
Using an automated search we first analysed cIRGs,
nIRGs and control genes, whose RNA abundance was
neither in the spleen nor in the lung affected by IFN


















Fig. 2 IFN treatment for the microarray experiment. a Four groups of chickens (n = 6 per group) received recChIFNα as indicated in the
experimental scheme. b At the indicated time points animals were sacrificed and the plasma concentration of biologically active type I IFN was
measured using an IFN reporter gene assay. Shown are group mean and individual IFN concentrations
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(Table 3). When a region 6 kb upstream of the first exon
to the last exon was taken as a basis for the search, ISRE
and GAS were identified in about a quarter of the genes
with a somewhat higher frequency (25 and 26%) in
cIRGs and nIRGs than in control genes (22%) and the
majority of regulatory elements being GAS. Interestingly,
when only the region 6 kb upstream of the transcription
start site, presumably the promotor region, was taken
into account the percentage of genes containing ISRE
and/or GAS motifs was in general very low and only
slightly higher in cIRGs (6%) and nIRGs (5%) than in
control genes (4%).
Tsukahara et al. had also found that in a standard
search, genes with higher mRNA abundance after IFN
treatment, genes with lower mRNA abundance and ran-
domly expressed genes contained almost the same por-
tion of ISRE and GAS elements [41]. To overcome this
problem, we performed a detailed manual search for the
30 most strongly affected genes (Additional file 4: Table
S4). With the exception of OAS, where neither an ISRE
a
b c
Fig. 3 Microarray analysis after IFN injection. a “R” based heat map of spleen and lung tissue: Probes are labeled by group membership and
animal number (1-4). Data sets with an unusual assignment which deviates from the rest of the group are boxed. b Venn diagram for the
comparison of microarray and in silico analysis: Shown are the intersections of significantly regulated genes 3 h after IFN injection between
spleen (red), lung (blue) tissue and the “common IRGs” (green), identified by database analysis. c Intersections of IRGs in spleen and lung at
different time points after IFN injection: Numbers indicate array-based significantly regulated genes; numbers in brackets represent “common IRGs”
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nor a GAS was found, all top 30 genes contained several
GAS elements. ISRE were only found in four genes in
the spleen (avidin, MMP1, LIPI, Mx) and three genes in
the lung (IFIT5, Mx, SOCS3) with avidin, MMP1 and
LIPI being nIRGs the others cIRGs. As Tsukahara et al.
also proposed an accumulation of ISRE close to the tran-
scription start site, we confined our search to 500 bp
upstream of the transcription start site. However, in this
region we found only one ISRE for IFIT5 and a strongly
reduced number of GASs.
In summary, ISREs and GASs could be identified only
in a minority of regulated genes but with identical re-
sults for cIRGS and nIRGs.
IRGs exhibit different expression profiles
The chosen experimental design with three different
time periods of IFN exposition allows for the generation
of expression courses for single genes over time. There-
fore, all genes differentially expressed in the group
exposed for 3 h were subjected to analysis by Multi ex-
periment Viewer (MeV). In total 1844 (99%, spleen) and
921 (97%, lung) of all regulated genes were assigned to
an expression profile. When the identified profiles were
compared and highly similar profiles were grouped, a
total of nine groups of expression profiles were found
(Fig. 4a and Table 4). One third of the genes belong to
profile 1 (solely up-regulated after 3 h) and one third to
profile 2 (solely down-regulated after 3 h), showing
again, that more than 60% of the regulated genes are
exclusively regulated after 3 h. Profiles 3 and 4, which
represent continuous up- and down-regulation over all
time points, contain another quarter of regulated genes.
Far less genes were assigned to profiles 5 to 9, which
contain genes with a diverse additional regulation at 6
and 9 h. Remarkably, the classical IRGs Mx (Mx1), OAS
(OAS) and PKR (EIF2AK2) have identical expression
profiles, they all show a continuously elevated abun-
dance and were assigned to profile 5 in the spleen and
profile 3 in the lung (Fig. 4b).
Profile 8, representing a continuous down regulation,
was not observed for IRGs in the lung. Interestingly,
profile 7 which shows a stair-like up-regulation after 3
and 9 h, contains only few genes, but these have a stron-
ger representation in the lung than in the spleen (31
genes vs. eight genes corresponding to 3.3 vs. 0.4% of all
genes). The same applies to the undulating profile 9,
which represents genes upregulated after 3 and again
after 9 h as only 0.5% of splenic but almost 10% of the
regulated lung genes belong to this profile. Overall,
expression profiles for the majority of differentially
expressed genes in spleen and lung were quite similarly
distributed. Of note, for minor subgroups of genes tissue
specific profiles were identified in the lung.
IL6 protein level reflects RNA abundance
The cIRG IL6 is well-known in mammals and in our array
experiment it was both in the spleen and in the lung
found among the genes with highest changes in abun-
dance. To verify the microarray data the very same sam-
ples were additionally analysed by q-RT-PCR. As Fig. 5a
shows, changes in RNA abundance detected by q-RT-PCR
were slightly higher than those obtained from the micro-
array. But all lay in the same range and resulted in identi-
cal IL6 expression profiles for spleen and lung.
RNA abundance is informative, but functional activity
is only exhibited by proteins. To test whether RNA
levels correspond to protein expression we used a bio-
assay to measure IL6 protein in plasma samples. As
Fig. 5b clearly shows, significant amounts of IL6 were
only detected in plasma samples taken 3 h after IFN
treatment. This peak expression reflects exactly RNA ex-
pression levels in the spleen. Hence either cytokines in
the spleen are rapidly released into the blood or the liver
as main producer for IL6 reacts like the spleen. The
lung’s IL6 expression profile differs substantially and
possible lung derived IL6 acts more locally.
Gene ontology and pathway analyses
In order to analyse which biological processes were influ-
enced by type I IFN treatment, Gene ontology (GO) ana-
lysis was performed looking at different aspects. Firstly, all
genes with an at least 3fold change in abundance were
subjected to Panther GO analysis (Fig. 6). Hereby, no
significant differences between up- and downregulated
genes and over time could be identified. In each data set
“cell communication”, “cellular process” and “metabolic
process” represented the functional classes with the high-
est percentage of affiliated genes. This was followed by
“developmetal process” and “immunological process”. In
addition, there were only minor differences between lung
Table 1 Number of differentially expressed genes after IFN
injection with a FC ≤ -2 or ≥ 2
# of genes
Spleen IFN (3 h) 1869 + 871
- 998
IFN (6 h) 852 + 316
- 536
IFN (9 h) 665 + 257
- 408
Lung IFN (3 h) 945 + 685
- 260
IFN (6 h) 435 + 372
- 63
IFN (9 h) 611 + 489
- 122
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Table 2 Top 30 of genes with the highest or least changes in mRNA abundance in spleen (A) and lung (B). The scanned region for
promotor elements ranged from 6 kb upstream to 1 kb downstream of the first exon
Gene
symbol







PTX3 Pentraxin related gene, rapidly induced by IL1 beta 685 3 h x x 0/7
SFTPA1 Surfactant, pulmonary-associated protein A1 −436 9 h x - 0/12
LOC396260 Mature avidin 384 9 h - x 1/7
IL6 Interleukin-6 186 3 h x x 0/8
LAO L-amino-acid oxidase precursor (Interleukin-4 induced 1) 169 3 h - x 0/7
K203 Chicken chemokine (C-C motif) L i 3 145 3 h - x 0/6
LL Lung lectin −140 9 h - - 0/12
PSCA Prostate stem cell antigen −124 9 h - - 0/12
KCNA1 Potassium voltage-gated channel, shaker-related
subfamily, member 1
−69 3 h - - 0/5
LYG2 Lysozyme G-like 2 62 3 h - x 0/6
CSF3 Colony stimulating factor 3 58 3 h x x 0/3
NEFH Neurofilament, heavy polypeptide −56 3 h - - 0/5
CMBL Carboxymethylenebutenolidase homolog 44 3 h - x 0/12
GCH1 GTP cyclohydrolase 1 43 3 h x x 0/9
FSHR Follicle stimulating hormone receptor −39 3 h - - 0/5
ZPD Zona pellucida protein D 38 3 h - - 0/13
IRG1 Immunoresponsive 1 homolog 35 3 h - x 0/9
BATF3 Basic leucine zipper transcription factor, ATF-like 3 35 3 h - x 0/11
IL22 Interleukin-22 34 3 h x x 0/4
MAOA Monoamine oxidase A 33 9 h - x 0/11
HPS5 Hermansky Pudlak syndrome 5 30 6 h x x 0/10
ETV1 ETS variant gene 1 −30 3 h - - 0/13
TULP1 Tubby like protein 1 28 3 h - x 0/11
MMP1 Matrix metallopeptidase 1 (interstitial collagenase) 27 3 h - x 1/7
LIPI Lipase, member I 26 3 h - x 1/9
RPL37 Ribosomal protein L37 26 3 h x x 0/9
GBP Guanylate binding protein 25 3 h x x 0/5
OAS 2‘5’oligoadenylate synthetase like 25 3 h x x 0/0
SPINK5 Serine peptidase inhibitor, Kazal type 5 −25 6 h - - 0/7
Mx1 Myxovirus (influenza virus) resistance-1 24 3 h x x 1/16
B)
TULP1 Tubby like protein 1 118 3 h - x 0/11
IL6 Interleukin-6 67 9 h x x 0/8
CMBL Carboxymethylenebutenolidase homolog 53 3 h - x 0/12
LOC396260 Mature avidin 44 9 h - x 1/7
LAO L-amino-acid oxidase precursor 40 3 h - x 0/7
MSC Musculin (activated B-cell factor-1) 33 3 h - x 0/5
FKBP5 FK506 binding protein 5 30 3 h x x 0/6
TGM4 Transglutaminase 4 (prostate) 24 3 h - - 0/10
LYG2 Lysozyme G-like 2 24 3 h - x 0/6
Röll et al. BMC Genomics  (2017) 18:264 Page 9 of 21
and spleen though in the lung proportionally more genes
belong to “apoptosis”.
Next, GO analysis was performed with separated data
sets for cIRGs and nIRGs, which were differentially
expressed either in spleen and lung or only the spleen or
only the lung. (Additional file 5: Figure S1A). Thereby nei-
ther examination of “molecular process” nor “biological
process” nor “cellular component” revealed significant dif-
ferences between cIRGs and nIRGs or between lung and
spleen. In all data sets analysed for biological processes
the subgroups “cell communication”, “cellular process”
and “metabolic process” were most strongly represented.
Among cIRGs the proportion of genes assigned to
“Immune system process” was slightly higher than among
the identified nIRGs. A more detailed analysis of the se-
lected data sets for “cellular process” showed that in all
groups “cell communication” is the most prominent sub-
class, mostly comprising genes which were assigned to
“cell cell signalling” (Additional file 5: Figure S1B).
Differentially expressed genes were also subjected to
Pathway Express. Table 5 shows the 30 most significantly
regulated pathways in spleen and lung after 3 h. In the
lung “Phosphatidyl-Inositol-Signalling system” was the
pathway with the highest level of significance being
assigned a corrected gamma p-value of 6,7×10−11.
Phosphatidyl-Inositol-Signalling is of major importance
for intracellular signalling and is involved in a multitude of
cellular processes like cell cycle progression, growth, motil-
ity, adhesion and survival [47]. Among the regulated genes
is PTEN (phosphatase and tensin homolog) with a 13.5-fold
upregulation. PTEN acts as a phosphatidylinositol-3,4,5-
trisphosphate 3-phosphatase and is known as a tumor
suppressor gene. It negatively regulates PI3K induced Akt-
Signalling and prevents uncontrolled, too fast cell divisions.
In the spleen “leukocyte transendothelial migration”
and “cell adhesion molecules” are ranked number one
and two, reflecting the migratory activation of leukocytes
in this central organ of the adaptive immune system.
They are followed by “JAK-STAT-“and “TLR-signalling”,
Table 2 Top 30 of genes with the highest or least changes in mRNA abundance in spleen (A) and lung (B). The scanned region for
promotor elements ranged from 6 kb upstream to 1 kb downstream of the first exon (Continued)
BATF3 Basic leucine zipper transcription factor, ATF-like 3 22 3 h - x 0/11
GBP Guanylate binding protein 22 3 h x x 0/5
RPL37 Ribosomal protein L37 20 3 + 9 h x x 0/9
IFIT-5 Interferon induced protein with tetratricopeptide repeats 5 18 3 + 9 h x x 1/9
IRG1 Immunoresponsive 1 homolog 19 9 h - x 0/9
TLR5 Toll-like receptor-5 −18 3 h x - 0/11
SEMA6D −17 3 h - x 0/11
GCH1 GTP cyclohydrolase 1 17 3 h x x 0/9
GAL9 Gallicin 9 16 3 h - - 0/8
Rd Riboflavin-binding protein 16 3 h - - 0/15
MAOA Monoamine oxidase A 16 9 h - x 0/11
SAMD9L Sterile alpha motif domain containing 9 like 15 3 + 9 h x x 0/13
K203 Chicken chemokine (C-C motif) L i 3 14 9 h - x 0/6
IL1RL1 Interleukin-1 receptor like 1 14 3 h x x 0/15
MX1 Myxovirus (influenza virus) resistance-1 13 3 + 6 + 9 h x x 1/16
SOCS3 Suppressor of cytokine signaling 3 12 9 h x x 1/9
RASD1 RAS, dexamethasone induced 1 12 3 h - x 0/3
OAS 2‘5’oligoadenylate synthetase like protein 11 3 h x x 0/0
ALB Albumin 10 3 h - - 0/12
PDK4 Pyruvate dehydrogenase kinase, isozyme 4 10 3 h x x 0/12
SNAP25 Synaptosomal-associated protein, 25 kDa −10 3 h x - 0/19
Table 3 Number and portion of chicken genes containing ISRE
and/or GAS motifs
Input Localisation ISRE/GAS Percent
Not sign. after IFN 9677 whole gene 87/2117 22
6 kb upstream 10/406 4
cIRG 383 whole gene 3/94 25
6 kb upstream 3/20 6
nIRG 2254 whole gene 13/575 26
6 kb upstream 3/102 5
Regions analysed were either 6 kb upstream of the first exon of the respective
gene referred to as “6 kb upstream” or from 6 kb upstream of the first exon
down to the last exon of the gene sequence, referred to as “whole gene”
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two pathways which play an essential role for the activa-
tion of the innate immune system and are also among
the top four pathways in the lung. Three hours after IFN
application TLR3 and TLR15 were upregulated in both
lung and spleen. TLR3, the intraendosomal receptor for
double stranded RNA, showed the strongest increase in
abundance of all TLRs with an FC of +10 in the lung
and +6 in the spleen and stayed upregulated at 6 and
9 h (lung: FC + 6 and +7; spleen FC +4 and +4). TLR15
is unique to reptiles and birds and binds a yeast compo-
nent [48]. In contrast to the short and relatively weak
upregulation in the spleen, we observed a continuous
upregulation in the lung (FC +4, +2 and +5 after 3, 6
and 9 h). Interestingly, TLR5, the receptor for flagellin,
was clearly downregulated in both tissues (FC –18 in the
lung), while no regulation was observed for TLR21, the
CpG motive binding chicken homologue of TLR9. In
C IFN (3h) IFN (6h) IFN (9h)
1 
Il-22 (S)
C IFN (3h) IFN (6h) IFN (9h)
3
Mature Avidin (S)
C IFN (3h) IFN (6h) IFN (9h)
2
KCNA 1 (S)
C IFN (3h) IFN (6h) IFN (9h)
4
MMP-13 (S)
C IFN (3h) IFN (6h) IFN (9h)
7
Il-6 (L)
C IFN (3h) IFN (6h) IFN (9h)
5
PTX 3 (S)
C IFN (3h) IFN (6h) IFN (9h)
9
RPL 37 (L)
C IFN (3h) IFN (6h) IFN (9h)
6
TLR 5 (L)















Fig. 4 IRGs exhibit different expression profiles. a MEV analysis of genes with differential expression after 3 h identified nine different groups of
expression profiles over the three sampling time points. Shown are characteristic examples for each group with gene name and tissue (S for spleen, L
for lung) for which the profile was found. b Comparison of profiles for Mx, OAS and PKR in spleen (black symbols) and lung (grey symbols)
Table 4 Expression profiles identified by MeV. Shown are the
numbers of genes assigned to the different clusters (see Fig. 4a),






Spleen Lung Spleen Lung
1 900 139 59 462 240
2 798 52 23 543 180
3 317 35 63 108 111
4 399 28 5 319 47
5 156 29 4 57 66
6 38 3 2 31 2
7 39 0 7 8 24
8 20 1 0 19 0
9 98 2 28 8 60
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addition to the TLR genes themselves, the important
signalling molecules TRAF3 and IRF7 were upregu-
lated, which after TLR stimulation lead to the ob-
served transcription of inflammatory cytokines (IL1ß,
IL6, IL12) and chemokines (IL8, MIP family members
and RANTES/CCLi4).
Another possibility to gain information about the con-
nection of differentially expressed genes is a network
analysis. Therefore, array data were subjected to the
Interactive Pathway analysis of complex ‘omics data
(IPA) from Ingenuity®. Several genes with interesting
features were manually chosen as so called “upstream
regulators” for a causal network analysis in order to
identify genes which are directly or indirectly connected
to the regulator. Exemplary, the networks for the highly
upregulated cIRGs PTX3 and IL22, the strongly down-
regulated cIRG SFTPA1 and the nIRG ALB (albumin)
are shown (Fig. 7 and Additional file 6: Figure S2).
With a 685fold upregulation (spleen, 3 h), PTX3 is the
gene with the highest FC of all tissues and timepoints.
As Fig. 7a shows, all of the known mammalian interac-
tors of PTX3 were likewise regulated after IFN treatment
in chickens, including several cytokines (IL1 and IL6),
TLRs (TLR2 and TLR4) and transcription factors (NFκB1
and JUN). Besides, the identified interactors represented
both cIRGs and nIRGs.
A nIRG for which an IPA network was found is Albu-
min (ALB) (Fig. 7 b). Albumin showed a 10fold upregu-
lation in the lung after 3 h but was not affected in the
spleen. IPA identified 14 significantly regulated genes to
interact with albumin, among them IL1, IL6, IL12 and
VEGF. And as for PTX3 interacting genes represent both
cIRGs and nIRGs.
IL22 was 34-fold upregulated in the spleen (3 h) and
3-fold upregulated in the lung (9 h). From the 28 (out of
34) annotated interactors of IL22, 22 were significantly
regulated by treatment with IFNα, thereby containing 14
cIRGs and 8 nIRGs (Additional file 6: Figure S2A).
Among the connected genes were both, inflammatory
cytokines (IL6, IL1, IL18) and regulators of an immune
response (SOCS3, CD274/PD-L1).
Surfactant protein A1 (SFTPA1) is highly interesting,
as it shows the strongest decrease in abundance with a
436fold downregulation in the spleen and exhibits its

















Fig. 5 Validation of array results. a Comparison of detected fold changes for IL6 mRNA from the microarray experiment and qRT-PCR on identical
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IFN(3h) IFN (6h) IFN(9h)
+ - + - + -
Spleen Lung
IFN(3h) IFN (6h) IFN(9h)
+ - + - + -
113 11 156 14
Fig. 6 Gene ontology of differentially expressed genes. Differentially expressed genes with an FC of at least ± 3 were subjected to Panther gene
ontology. Shown are identified biological processes and their percental distribution between genes with higher (+) and lower (-) mRNA
abundance after IFN injection in spleen and lung
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function through reduced expression. IPA identified 49
interacting genes, from which 31 were annotated on the
microarray. Additional file 6: Figure S2B shows that
about half of the known mammalian interactors were
significantly affected in the chicken, nine of them being
cIRGs and 13 belonging to the identified nIRGs.
Overall, IPA network analysis, a tool based on human,
mouse and rat data, demonstrates that networks which
were initially described in mammals are to a large part
also activated in chickens and connected genes are quite
equally distributed between cIRGs and nIRGs.
Cytokines and chemokines
A main effect of type I interferon on cells is to induce
an antiviral state e.g. by the induction of Mx, PKR and
OAS. Yet, GO analysis and Pathway express show that
cell communication and cytokine signalling are as well
strongly activated. As we added a multitude of probe sets
Table 5 KEGG Pathway Express analysis
Spleen Lung












Leukocyte transendothelial migration 1 138.9 16/119 6.56E-59 52 3.1 7/119 0.190507
Cell adhesion molecules (CAMs) 2 123.4 15/134 3.30E-52 54 2.9 7/134 0.209069
Phosphatidylinositol signaling system 21 5.7 6/76 0.02196 1 27.5 7/76 3.22E-11
Jak-STAT signaling pathway 3 16.0 32/155 2.00E-06 2 18.7 24/155 1.55E-07
Toll-like receptor signaling pathway 4 14.9 24/102 5.22E-06 3 17.2 19/102 6.12E-07
Circadian rhythm 11 8.5 3/13 0.00192 4 17.1 1/13 7.32E-07
Graft-versus-host disease 5 14.4 6/42 8.59E-06 7 11.7 6/42 1.02E-04
Pathways in cancer 6 13.6 63/330 1.89E-05 5 13.4 39/330 2.19E-05
Complement and coagulation cascades 31 4.0 11/69 0.08904 6 12.7 13/69 4.11E-05
Axon guidance 7 12.4 30/129 5.31E-05 49 3.2 9/129 0.174755
Bladder cancer 8 11.7 14/42 1.05E-04 35 3.9 5/42 0.098477
Hematopoietic cell lineage 9 11.6 17/87 1.19E-04 9 8.5 11/87 0.001957
MAPK signaling pathway 10 10.9 44/272 2.21E-04 24 4.7 19/272 0.052229
TGF-beta signaling pathway 35 3.8 13/87 0.10746 8 8.9 13/87 0.001400
ECM-receptor interaction 12 7.9 20/84 0.00334 10 8.1 13/84 0.002819
Type II diabetes mellitus 22 5.6 7/45 0.02363 11 8.0 7/45 0.003114
Long-term depression 13 7.8 17/75 0.00361 44 3.2 2/75 0.170290
Calcium signaling pathway 38 3.7 23/182 0.11330 13 7.6 17/182 0.004315
Type I diabetes mellitus 14 7.5 8/44 0.00464 12 7.6 6/44 0.004176
Adherens junction 15 7.0 11/78 0.00718 33 4.0 3/78 0.091871
Allograft rejection 16 7.0 7/38 0.00741 15 6.7 5/38 0.009661
Epithelial cell signaling in Helicobacter
pylori infection
17 6.9 15/68 0.008295 16 6.4 9/68 0.011897
Apoptosis 25 5.5 15/89 0.02658 14 6.8 11/89 0.008871
Amyotrophic lateral sclerosis (ALS) 18 6.4 10/56 0.01234 39 3.6 5/56 0.123832
Focal adhesion 19 6.2 35/203 0.01415 34 4.0 17/203 0.095007
Small cell lung cancer 20 6.0 18/86 0.017727 30 4.1 9/86 0.083372
Systemic lupus erythematosus 26 5.4 10/144 0.02984 17 5.7 7/144 0.021797
GnRH signaling pathway 23 5.6 18/103 0.02426 32 4.1 8/103 0.085545
PPAR signaling pathway 24 5.6 14/70 0.02482 - - - -
Long-term potentiation 41 3.3 11/73 0.15896 19 5.4 5/73 0.028017
Shown are the 30 most significantly affected pathways in spleen and lung ranked according to their corrected gamma p-value (the value which was used for the
ranking is shown in bold letters); “Rank” is the rank of a pathway among all significantly affected pathways according to its impact factor; the “Impact factor” of a
pathway is calculated from a probabilistic term considering the proportion of differentially regulated genes on the pathway and gene perturbation factors of all
genes in the pathway [46]
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for cytokine and chemokine genes and their receptors to
the applied array-system, a closer examination of these
cellular communicators was possible. About 20% of the
Top30 genes in the spleen belong to cytokines and chemo-
kines and IL6 and CCLi3/K203, a chicken CC-chemokine
and putative homologue to human CCL16, were among
the genes with strongest upregulation in spleen (IL6 + 186;
K203 + 170) and lung (IL6 + 67; K203 + 16).
As Table 6 shows, IFN treatment leads to expression
changes of both inflammatory and homeostatic chemo-
kines. Among the regulated inflammatory chemokines
were members of the MIP family (CCLi3, CCLi4), the
MCP family (CCLi9) and both IL8 orthologs (CXCLi1
and CXCLi2). Among the homeostatic chemokines, ex-
pression of all four CCL family representatives (CCL17,




3h 6h 9h 3h 6h 9h
Fig. 7 Multilayer interaction of differentially expressed genes. IPA network analysis demonstrating gene interactions with the upstream regulators
PTX3 (a) and Albumin (b). Genes with higher mRNA abundance in the IFN treated animals are shown in red, genes with lower mRNA abundance
in the treated animals in green. The small diagrams next to each differentially expressed gene display expression (FC) at the different time points.
The magnification shows the expression course for IL6
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CXCL13 were regulated. Interestingly, the majority of
chemokines in the spleen shows an early increase in
abundance after 3 h (ten out of 15) with close to control
levels after 9 h, while the opposite is seen in the lung,
where expression levels for the majority of chemokines
rise up to 9 h (Fig. 8a and b). For CCLi3 (K203), CXCLi1
(K60) and CXCLi2 (IL8) this results in inverted profiles
in spleen and lung, demonstrating again a highly tissue
specific response.
Even more clear-cut is the picture for the regulated
cytokines (Table 7 and Fig. 8c and d). Altogether IFN
treatment altered the abundance of 15 cytokines and al-
most all highly induced cytokine genes (IL6, CSF3, IL22,
IL1 and IFNγ) show the above described inverted ex-
pression profiles in spleen and lung with highest abun-
dances after 3 h in the spleen and 9 h in the lung.
Discussion
Methodical aspects
Though type I IFNs were first described in the chicken,
the vast majority of available information about these
cytokines is derived from human and mouse studies. Re-
cently it became clear that the pleiotropic functions of
type I IFNs are mediated by the regulation of a huge
number of genes. As the chicken’s immune system dif-
fers significantly to that of human and mouse we aimed
for a better understanding of the chicken’s response to
IFNα. The performed database analysis identified more
than 1400 human/murine IRGs which are also present
in the chicken genome. As the existence of such a gene
does not necessarily argue for its regulation by IFN,
birds were intravenously treated with IFNα and changes
in gene expression were analysed in lung (the target
tissue of many important pathogens like AIV, IBV, NDV,
APEC) and spleen (the most prominent secondary
lymphatic tissue in birds). The setting evidently differs
from a naturally occurring lung infection, where a local
immune response with production of type I IFN would
be induced first, which then could become systemic.
However, it avoids the mixture of effects seen in a
natural immune response, where several cytokines and
effector molecules are induced in parallel.
In order to apply biologically relevant amounts of IFN,
we first determined the pharmacokinetic profile of re-
combinant chIFN in chickens. With a terminal half-life
of approximately 36 min it is clearly shorter than the
Table 6 Fold expression of differentially expressed chemokines and chemokine receptors after IFN treatment
Spleen Lung
Gene symbol IFN (3 h) IFN (6 h) IFN (9 h) IFN (3 h) IFN (6 h) IFN (9 h)
CCLi3 145 10 5 3 3 14
CCLi6 17 2 - - - -
CCLi9 3 5 6 6 11 17
CXCL13L2 9 11 13 3 4 7
CCL19 6 5 4 13 8 11
CXCLi2 3 - - 2 2 8
CX3CL1 6 3 - 2 - 2
CXCLi1 5 2 2 2 2 5
CXCL13L1 - - 2 3 3 5
CCL20 4 - - 2 - 2
CCL21 - 3 3 4 2 2
CCLi4 3 −2 −2 4 3 -
CCL17 3 −2 −4 3 - -
XCL1 −2 - - - - -
CXCL12 −4 - - - - -
CXCR4 5 - - - - -
CCRa 2 3 2 4 3 3
CCR7 - - - 2 - 2
CCR8 2 - - - - -
XCR1 −2 - −2 - - -
CXCR7 - - - −2 - −2
CCR6 −3 - −2 - - -
CX3CR1 −5 - - - - -
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half-life reported for human IFNα (4-6 h) or human
IFNβ in humans (1-2 h) [49], an observation which can
possibly be attributed to the higher metabolic activity in
birds. Using an application setting based on these data
we were able to obtain a constant IFN level during the
experiment comparable to levels observed during natural
occurring viral infections [20].
Heatmap analysis of the performed arrays already
showed two things: firstly, strong effects of IFN on gene
expression in both tissues studied with a clear separation
of treated and control birds and secondly, explicit differ-
ences between spleen and lung. As expected a closer
look at the differentially expressed genes showed a
strong induction of IRGs Mx, OAS and PKR, thus prov-
ing the reliability of the experiment. Regarding the time
point of expression the vast majority of differentially
expressed genes (86% in the spleen and 80% in the lung)
was found 3 h after IFNα application.
Surprisingly, we observed relatively little concordance
between our in silico and in vivo analyses, with many
IRGs identified in the database search being not differ-
entially expressed in the array and many differentially
expressed genes having not been found in the database.
In agreement with our observation Giotis and colleagues
analyzed IRGs in IFNα treated chicken embryo fibro-
blasts (CEF) and they also identified many potential
chicken IRGs with no equivalent in the Interferome
database [29]. Partly, annotation problems could be a
reason as entries in the database and the chicken gen-
ome use a different nomenclature, hence mammalian
IRGs were not found on the array. Nevertheless, it is
very unlikely that this applies but for all 70% of the
genes without mammalian equivalent. The finding of so
many additional differentially expressed genes might
have been facilitated by the usage of a strong stimulation
and the high sensitivity of the array. Furthermore, we
analyzed both increased and reduced expression of
target genes, while many other approaches were only
focused on positively affected, so called “Interferon Stim-
ulated Genes” (ISGs) [13, 29]. Among the 30 most af-
fected genes in the spleen were eight with reduced
expression and only one of them (SFTPA1) was also
identified in the database search.
Other reasons for the discrepancy between in silico
and array results might be time-, tissue- and species spe-
cificity. Database entries comprise a multitude of tissues
and cells with different times of IFN exposition [12].
Our analysis demonstrates large differences between the









































































Fig. 8 Tissue and time specific expression profiles for chemokines and cytokines. Fold expression of differentially expressed chemokines (a + b)
and cytokines (c + d) after IFN injection in the spleen (a + c) and the lung (b + d) in relation to control birds
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Table 7 Fold expression of differentially expressed cytokines and cytokine receptors after IFN treatment
Spleen Lung
Gene Symbol IFN (3 h) IFN (6 h) IFN (9 h) IFN (3 h) IFN (6 h) IFN (9 h)
IL6 186 10 11 7 12 67
CSF3 58 - - - - 7
IL22 34 - 3 - - 3
IL1B 14 - - 4 4 14
IL18 12 4 3 4 3 4
IFNG 10 2 2 2 3 9
CD40 8 3 - - - -
TNFSF8 7 - - - - -
IL12B −2 - - 3 6 4
IL2 5 - - 3 - 3
IL17F 5 - 2 - - -
TNFSF15 5 - - - - -
FAS 3 - - 3 - 2
IL12A 3 - - - - -
TNFSF10 3 3 - - - -
TNFSF13B - - - 2 - -
TNFSF11 - - −2 - - -
IL7 −3 - - - - -
TRAIL −3 - - - - -
IL1RL1 15 5 3 14 3 3
IL13RA2 13 7 6 14 12 18
TNFRSF8 9 3 4 - - -
IL1R2 7 3 - 3 - -
TNFRSF11B 3 - - 5 - -
CSF3R - 4 4 - 2 2
IL20RA 4 3 - 3 - -
CSF2RB 4 - - 3 - 2
IL2RA 4 - - - - 2
IL23R 4 2 - - - -
CSF2RA 3 2 - 3 3 3
IL10RB 3 - - 2 - -
TNFRSF1B 3 - - 2 - -
IL21R 2 - - 3 - -
TNFRSF1A - - - 2 - 3
IFNGR1 3 - - - - -
IL4R 3 - - - - -
IL1R1 3 - - - - -
IFNAR1 2 - - 2 - -
TNFRSF13C 2 - - - - -
IL7R 2 - - - - -
IL10RA 2 - - - - -
IL12RB2 −2 - - - - -
IL28RA −2 - - - - -
IL1RL2 - −2 −2 - - -
IL11RA −3 - - - - -
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two examined tissues and three examined time points.
Hence, testing of additional tissues and time points
might reveal further differentially expressed genes and a
larger overlap with the database search. And despite the
general conservation of the IFN pathway some IRGs
might be species specific.
cIRGs and nIRGs
The fact that so many differentially expressed genes had
not been found in the database search suggested to dis-
criminate between common (database) IRGs (cIRGs) and
newly (only in the microarray) identified IRGs (nIRGs).
To increase the probability that identified nIRGs are truly
regulated by interferon, only genes differentially expressed
after 3 h of IFN exposition were considered as IRGs and
used for downstream analyses as at later time points
secondary effects could not be excluded. For instance IL6
expression was strongly induced and high amounts of pro-
tein were found after 3 h (Fig. 5). As IL6 itself induces an
inflammatory reaction, at later time points genes could be
regulated by IL6 instead of IFN.
Another approach to compare cIRGs and nIRGs was
the search for ISRE and GAS elements. Unfortunately,
an automated search did identify only a very low num-
ber of both of them in the promotor region of the ana-
lysed genes and did not reveal clear differences between
both groups of IRGs and control genes. The low overall
coverage is possibly caused by weak sequence conserva-
tion between chicken on the one hand and mouse and
man on the other. Additionally, due to technical limita-
tions we were only able to screen a portion of func-
tional ISRE and GAS elements and may have missed
chicken specific ISRE and GAS elements or so far un-
identified ISRE and GAS elements which are conserved
across species.
More successful was the individual screening of the 30
most strongly affected genes, were with one exception in
every gene an ISRE or GAS element was identified. Sur-
prisingly, in contrast to mammalian data [41] far more
GAS than ISRE elements were found, but it has already
been shown that type I IFN induced transcription factors
are able to activate GAS elements [44]. So, despite its
limitations, the promotor analysis revealed identical
motive distribution in cIRGs and nIRGs.
IPA interaction shows that upstream regulators
interact equally with cIRGs and nIRGs and the GO
and pathway distribution of both groups is largely
identical. The fact that “Immune system process” was
slightly stronger represented among cIRGs than in
nIRGs, might be caused by a stronger focus on im-
mune genes of the used databases. Overall, we think
it is very likely that expression of the identified nIRGs
is regulated by IFN.
Tissue and time specificity
The heatmap analysis had already pointed to a tissue spe-
cific reaction to IFN exposure. The clear separation of the
3 h expression pattern in the spleen points to a fast peak-
ing response while the larger similarities between 3, 6 and
9 h in the lung suggest a slower and more sustained re-
action of this organ. Changes in RNA abundance support
this observation, as these were in general stronger in the
spleen, where also twice as many differentially expressed
genes were identified. For instance absolute changes of
Mx, OAS and PKR abundance were clearly higher in the
spleen and the expression profiles of these IRGs show a
strong 3 h peak in the spleen versus a continuous up regu-
lation (plateau) in the lung.
Though the receptor for type I IFN is ubiquitously
expressed [50] and theoretically every cell can react to
IFN stimulation, the more homogenous tissue compos-
ition of the spleen might lead to more intense variations
than in the heterogeneous lung, where the cartilaginous
parts might react differently from epithelium and lung
associated immune cells. In addition, immune cells may
show a more pronounced reactivity per se and this dif-
ference might have been increased as we, on purpose,
did exclude large lymphoid structures in lung samples
by avoiding major BALT regions during sampling.
Tissue specificity is also underlined by pathway ana-
lysis, as the most strongly affected pathways differ in
spleen and lung. Interestingly, the two main pathways in
the spleen “Leukocyte transendothelial migration” and
“Cell adhesion molecules” were also the most affected
after infection with IBDV [51]. As one would expect,
IBDV infection led to the expression of type I IFN, but
in parallel also IFNγ as well as many other cytokines
were induced. Even though the stimuli were heteroge-
neous in the IBDV experiment the reaction pattern of
the spleen was similar to a sole stimulation with IFNα,
supporting the idea of a tissue specific reaction.
Tissue specificity is not only presented by the diversity
of affected genes but also by time specific expression pat-
terns. Generation of expression courses for all differen-
tially expressed genes revealed that two thirds of the genes
affected in both tissues are solely up- or downregulated
after 3 h of IFN exposition. However, profiles with up
regulation after 9 h are proportionately much stronger
represented in the lung than the spleen. This is for in-
stance shown by expression profiles of regulated chemo-
kine and cytokine genes. In many of these profiles the
spleen reacts early and the lung reacts late, leading to op-
posite profiles e.g. for inflammatory chemokines (CCLi3
(K203), CXCLi1 (K60), CXCLi2 (IL8)) and inflammatory
cytokines (IL1, IL6). Interestingly, this time specific reac-
tion of IRGs was also observed in a transcriptome analysis
of cultured CEF [29] and hence seems to be more of a
general phenomenon than restricted to lung or spleen.
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Conserved interaction of selected upstream regulators
Network analysis with selected “upstream regulators”
suggests a widely conserved interaction pattern for
chicken IRGs as many of the known mammalian interac-
tors are also affected in the chicken.
PTX3, the gene with the highest fold change (FC), is a
member of the pentraxin superfamily like the acute
phase proteins CRP (C reactive protein) and Serum
Amyloid P Component (SAP) and acts as Pattern Recog-
nition receptor (PRR). During inflammatory processes
PTX3 is rapidly produced by macrophages, dendritic
cells, fibroblasts and epithelial cells [52]. It is known to
activate the classical pathway of the complement system
and facilitates pathogen recognition by DCs and MQs
[52–54]. By binding to hemagglutinin it is also able to
inhibit infectivity of influenza viruses [55]. In mammals
PTX3 is known to directly and indirectly influence cyto-
kines and their receptors, growth factors, G-protein
coupled receptors, peptidases and transcription factors
[56]. As we found regulation of IL1, IL6, IGF1 and also
NFkB and Jun, chicken PTX3 seems to have a similar
mode of action.
Serum albumin is a “negative acute-phase protein”,
which means its abundance decreases during an acute-
phase-response, probably to save amino acids for posi-
tive acute phase proteins [57, 58]. The IFNα induced
upregulation of albumin in the lung strongly argues for
an active function of this protein as indicated by the
connection with several cytokines and chemokines. It is
known that human albumin protects tissue against oxi-
dative stress by blocking reactive oxygen species (ROS)
from neutrophils [59, 60]. Hence, albumin could protect
the lung against deleterious side effects of IFN.
For Surfactant protein A1 (SFTPA1) we found the
strongest decrease of RNA abundance. Reduced expres-
sion of SFTPA1 was also observed in infection studies
with chickens using ILTV (Infectious Lanryngotracheitis
Virus) and Avian Influenza Virus H9N2 [61, 62], possibly
mediated by virus induced IFN. It was shown that sup-
pression of the P38 MAPK and the PI-3 kinase pathway
can downregulate SFTPA1 [63, 64] and especially for the
PI-3 kinase pathway we observed a very strong activa-
tion in spleens and lung. Two thirds of the IPA anno-
tated interactors were also found in the chicken and
among them are several proinflammatory cytokines (IL1,
IL6), whose production can be suppressed by SFTPA1
[65]. Hence reduced SFTPA1 abundance allows for a
higher induction of proinflammatory cytokines and a
stronger IFN induced immune response.
IL22, a strongly upregulated cIRG is a member of the
IL10 superfamily. Being pro-regenerative, pro-proliferative
and anti-apoptotic its main function is to modulate the tis-
sue response during an inflammatory reaction [66]. The
interactors for IL22 which we identified in our data set
follow the idea of a modulating cytokine as both inflam-
matory factors and regulators of an immune response were
found. While IL22 is exclusively produced by leukocytes of
the innate and adaptive immune system, the IL22R is
mostly expressed on epithelial cells [67]. In mice a close
interaction of IL22 and IFNα and IFNλ, respectively was
demonstrated for lung and gut and this interplay between
IL22 and interferon seems also be true for the chicken.
Sensitization and desensitization
For several species it was shown that pathogen recogni-
tion induces the production of type I IFN and induces a
multitude of effector mechanisms. In addition, exposure
of cells to IFN does sensitize the cells for further detec-
tion of pathogens [6]. In our studies this was also dem-
onstrated for chicken cells as IFN treatment upregulated
TLRs for RNA and yeast detection, the RNA detecting
OAS and the cytosolic NOD-like receptor NLRC5.
NLRC5 shows a close evolutionary relationship to
NLRC1 and NLRC2 and hence is probably involved in
detection of bacterial infections [68].
In mice it was shown that in most cells pathogen sens-
ing leads first to the expression of IFNβ, which then in-
duces an amplification step IFNα [7]. We did not find
upregulation of mRNA for type I IFNs, which might be
caused by the artificial setting or a different induction
mechanism in the chicken. In contrast to type I IFNs,
IFNγ was upregulated in spleen and lung and showed
the described inverted expression profiles. This shows
that type I IFN is not only a strong effector of the innate
immune response but by inducing IRGs like IFNγ, IL18,
IL2 and CXCL13 does also activate adaptive immunity.
IFN signalling can induce a powerful inflammatory im-
mune response and therefore needs to be tightly con-
trolled. Once an IFN response is initiated desensitization
of cells is induced in parallel by several mechanisms. One
proposed mechanism is downregulation of the IFN recep-
tor, but we found a slight upregulation of IFNAR1 RNA
after 3 h. In mammals, the action of SOCS (suppressor of
cytokine signalling) proteins, which inhibit JAK-STAT sig-
nalling, is well described as early desensitizing mechanism.
The same seems to be applicable to chickens as a signifi-
cant upregulation of SOCS1 and SOCS3 in spleen and
lung, with a strong 3 h peak in the spleen and a plateau in
the spleen was obseved. USP18 does maintain long-term
desensitization by either removing ISG15 conjugated pro-
teins or intracellular binding to IFNAR2 [69, 70]. Strong
upregulation of USP18 in spleen and lung after 3 h dem-
onstrates the conservation of negative control mecha-
nisms of the type I IFN response in chickens.
Conclusion
The application of a constant, physiological amount of
IFNα over 9 h affected a multitude of IRGs in spleen
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and lung. We identified many different expression pro-
files and found that induction/suppression of IRGs is
both tissue and time specific. It became apparent that
type I IFN does not only induce antiviral mechanisms
but also mediates a multitude of different functions. As
we found little overlap of our data with existing data-
bases, we here provide a large new dataset for further
research, both to expand the data set by further tissues
and time points and to examine single IRGs for their in-
dividual function. Our study provides the basis for the
potential identification of new antiviral mechanisms with
broader screening approaches using RNA interference or
gene editing technologies like CRISPR/Cas9.
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